A citation-based method for searching scientific literature

Christian van der Werf, Prince J Kannankeril, Frederic Sacher, Andrew D Krahn, Sami Viskin, Antoine Leenhardt, Wataru Shimizu, Naokata Sumitomo, Frank A Fish, Zahurul A Bhuiyan, Albert R Willems, Maurits J van der Veen, Hiroshi Watanabe, Julien Laborderie, Michel Haïssaguerre, Björn C Knollmann, Arthur A M Wilde. J Am Coll Cardiol 2011
Times Cited: 241







List of co-cited articles
2741 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.
Meiso Hayashi, Isabelle Denjoy, Fabrice Extramiana, Alice Maltret, Nathalie Roux Buisson, Jean-Marc Lupoglazoff, Didier Klug, Miyuki Hayashi, Seiji Takatsuki, Elisabeth Villain,[...]. Circulation 2009
292
54

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.
Hiroshi Watanabe, Nagesh Chopra, Derek Laver, Hyun Seok Hwang, Sean S Davies, Daniel E Roach, Henry J Duff, Dan M Roden, Arthur A M Wilde, Björn C Knollmann. Nat Med 2009
372
48

HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.
Silvia G Priori, Arthur A Wilde, Minoru Horie, Yongkeun Cho, Elijah R Behr, Charles Berul, Nico Blom, Josep Brugada, Chern-En Chiang, Heikki Huikuri,[...]. Heart Rhythm 2013
47

Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.
A Leenhardt, V Lucet, I Denjoy, F Grau, D D Ngoc, P Coumel. Circulation 1995
603
47

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
Silvia G Priori, Carlo Napolitano, Mirella Memmi, Barbara Colombi, Fabrizio Drago, Maurizio Gasparini, Luciano DeSimone, Fernando Coltorti, Raffaella Bloise, Roberto Keegan,[...]. Circulation 2002
729
45

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
S G Priori, C Napolitano, N Tiso, M Memmi, G Vignati, R Bloise, V Sorrentino, G A Danieli. Circulation 2001
910
35

Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.
Thomas M Roston, Jeffrey M Vinocur, Kathleen R Maginot, Saira Mohammed, Jack C Salerno, Susan P Etheridge, Mitchell Cohen, Robert M Hamilton, Andreas Pflaumer, Ronald J Kanter,[...]. Circ Arrhythm Electrophysiol 2015
124
35

Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.
Gaetano M De Ferrari, Veronica Dusi, Carla Spazzolini, J Martijn Bos, Dominic J Abrams, Charles I Berul, Lia Crotti, Andrew M Davis, Michael Eldar, Maria Kharlap,[...]. Circulation 2015
143
35

Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia.
Arthur A M Wilde, Zahurul A Bhuiyan, Lia Crotti, Mario Facchini, Gaetano M De Ferrari, Thomas Paul, Chiara Ferrandi, Dave R Koolbergen, Attilio Odero, Peter J Schwartz. N Engl J Med 2008
270
31

Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.
Mette Nyegaard, Michael T Overgaard, Mads T Søndergaard, Marta Vranas, Elijah R Behr, Lasse L Hildebrandt, Jacob Lund, Paula L Hedley, A John Camm, Göran Wettrell,[...]. Am J Hum Genet 2012
219
26

Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Ferran Roses-Noguer, Julian W E Jarman, Jonathan R Clague, Jan Till. Heart Rhythm 2014
60
41


A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.
H Lahat, E Pras, T Olender, N Avidan, E Ben-Asher, O Man, E Levy-Nissenbaum, A Khoury, A Lorber, B Goldman,[...]. Am J Hum Genet 2001
440
24

Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia.
Hiroshi Watanabe, Christian van der Werf, Ferran Roses-Noguer, Arnon Adler, Naokata Sumitomo, Christian Veltmann, Raphael Rosso, Zahurul A Bhuiyan, Hennie Bikker, Prince J Kannankeril,[...]. Heart Rhythm 2013
55
41


Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death.
N Sumitomo, K Harada, M Nagashima, T Yasuda, Y Nakamura, Y Aragaki, A Saito, K Kurosaki, K Jouo, M Koujiro,[...]. Heart 2003
238
22

Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
Prince J Kannankeril, Jeremy P Moore, Marina Cerrone, Silvia G Priori, Naomi J Kertesz, Pamela S Ro, Anjan S Batra, Elizabeth S Kaufman, David L Fairbrother, Elizabeth V Saarel,[...]. JAMA Cardiol 2017
65
33


Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia.
P J Laitinen, K M Brown, K Piippo, H Swan, J M Devaney, B Brahmbhatt, E A Donarum, M Marino, N Tiso, M Viitasalo,[...]. Circulation 2001
500
20

Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.
Fredrick A Hilliard, Derek S Steele, Derek Laver, Zhaokang Yang, Sylvain J Le Marchand, Nagesh Chopra, David W Piston, Sabine Huke, Björn C Knollmann. J Mol Cell Cardiol 2010
161
19

Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
Christian van der Werf, Ineke Nederend, Nynke Hofman, Nan van Geloven, Corné Ebink, Ingrid M E Frohn-Mulder, A Marco W Alings, Hans A Bosker, Frank A Bracke, Freek van den Heuvel,[...]. Circ Arrhythm Electrophysiol 2012
92
20

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
Rafael Rosso, Jonathan M Kalman, Ori Rogowski, Shmuel Diamant, Amir Birger, Simon Biner, Bernard Belhassen, Sami Viskin. Heart Rhythm 2007
109
18

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
Raymond W Sy, Michael H Gollob, George J Klein, Raymond Yee, Allan C Skanes, Lorne J Gula, Peter Leong-Sit, Robert M Gow, Martin S Green, David H Birnie,[...]. Heart Rhythm 2011
115
17

Long-term follow-up of patients with short QT syndrome.
Carla Giustetto, Rainer Schimpf, Andrea Mazzanti, Chiara Scrocco, Philippe Maury, Olli Anttonen, Vincent Probst, Jean-Jacques Blanc, Pascal Sbragia, Paola Dalmasso,[...]. J Am Coll Cardiol 2011
171
17

The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2.
Mark L Bannister, N Lowri Thomas, Markus B Sikkel, Saptarshi Mukherjee, Chloe Maxwell, Kenneth T MacLeod, Christopher H George, Alan J Williams. Circ Res 2015
57
29

High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures".
G Michael Vincent, Peter J Schwartz, Isabelle Denjoy, Heikki Swan, Candice Bithell, Carla Spazzolini, Lia Crotti, Kirsi Piippo, Jean-Marc Lupoglazoff, Elizabeth Villain,[...]. Circulation 2009
186
17

Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.
Hyun Seok Hwang, Can Hasdemir, Derek Laver, Divya Mehra, Kutsal Turhan, Michela Faggioni, Huiyong Yin, Björn C Knollmann. Circ Arrhythm Electrophysiol 2011
85
18

Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade.
Gareth J Padfield, Leenah AlAhmari, Krystien V V Lieve, Tasneem AlAhmari, Thomas M Roston, Arthur A Wilde, Andrew D Krahn, Shubhayan Sanatani. Heart Rhythm 2016
29
55



Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry.
V Probst, C Veltmann, L Eckardt, P G Meregalli, F Gaita, H L Tan, D Babuty, F Sacher, C Giustetto, E Schulze-Bahr,[...]. Circulation 2010
476
16

Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
Silvia G Priori, Maurizio Gasparini, Carlo Napolitano, Paolo Della Bella, Andrea Ghidini Ottonelli, Biagio Sassone, Umberto Giordano, Carlo Pappone, Giosuè Mascioli, Guido Rossetti,[...]. J Am Coll Cardiol 2012
356
16

Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
Christina Y Miyake, Gregory Webster, Richard J Czosek, Michal J Kantoch, Anne M Dubin, Kishor Avasarala, Joseph Atallah. Circ Arrhythm Electrophysiol 2013
63
23

Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol.
Priya Chockalingam, Lia Crotti, Giulia Girardengo, Jonathan N Johnson, Katy M Harris, Jeroen F van der Heijden, Richard N W Hauer, Britt M Beckmann, Carla Spazzolini, Roberto Rordorf,[...]. J Am Coll Cardiol 2012
132
15

Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.
Nian Liu, Marco Denegri, Yanfei Ruan, José Everardo Avelino-Cruz, Andrea Perissi, Sara Negri, Carlo Napolitano, William A Coetzee, Penelope A Boyden, Silvia G Priori. Circ Res 2011
77
19

Risk stratification in the long-QT syndrome.
Silvia G Priori, Peter J Schwartz, Carlo Napolitano, Raffaella Bloise, Elena Ronchetti, Massimiliano Grillo, Alessandro Vicentini, Carla Spazzolini, Janni Nastoli, Georgia Bottelli,[...]. N Engl J Med 2003
903
15

Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing.
David J Tester, Argelia Medeiros-Domingo, Melissa L Will, Carla M Haglund, Michael J Ackerman. Mayo Clin Proc 2012
158
15

Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.
Silvia G Priori, Carlo Napolitano, Peter J Schwartz, Massimiliano Grillo, Raffaella Bloise, Elena Ronchetti, Cinzia Moncalvo, Chiara Tulipani, Alessia Veia, Georgia Bottelli,[...]. JAMA 2004
404
15

Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome.
Peter J Schwartz, Silvia G Priori, Marina Cerrone, Carla Spazzolini, Attilio Odero, Carlo Napolitano, Raffaella Bloise, Gaetano M De Ferrari, Catherine Klersy, Arthur J Moss,[...]. Circulation 2004
420
15

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
D S Echt, P R Liebson, L B Mitchell, R W Peters, D Obias-Manno, A H Barker, D Arensberg, A Baker, L Friedman, H L Greene. N Engl J Med 1991
14

The short QT syndrome: proposed diagnostic criteria.
Michael H Gollob, Calum J Redpath, Jason D Roberts. J Am Coll Cardiol 2011
163
14

Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human.
Nathalie Roux-Buisson, Marine Cacheux, Anne Fourest-Lieuvin, Jeremy Fauconnier, Julie Brocard, Isabelle Denjoy, Philippe Durand, Pascale Guicheney, Florence Kyndt, Antoine Leenhardt,[...]. Hum Mol Genet 2012
154
14

Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium.
Koonlawee Nademanee, Gumpanart Veerakul, Pakorn Chandanamattha, Lertlak Chaothawee, Aekarach Ariyachaipanich, Kriengkrai Jirasirirojanakorn, Khanchit Likittanasombat, Kiertijai Bhuripanyo, Tachapong Ngarmukos. Circulation 2011
419
14

Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
Cynthia A James, Aditya Bhonsale, Crystal Tichnell, Brittney Murray, Stuart D Russell, Harikrishna Tandri, Ryan J Tedford, Daniel P Judge, Hugh Calkins. J Am Coll Cardiol 2013
346
14

J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance.
Raphael Rosso, Evgeni Kogan, Bernard Belhassen, Uri Rozovski, Melvin M Scheinman, David Zeltser, Amir Halkin, Arie Steinvil, Karin Heller, Michael Glikson,[...]. J Am Coll Cardiol 2008
385
13

Sudden cardiac arrest associated with early repolarization.
Michel Haïssaguerre, Nicolas Derval, Frederic Sacher, Laurence Jesel, Isabel Deisenhofer, Luc de Roy, Jean-Luc Pasquié, Akihiko Nogami, Dominique Babuty, Sinikka Yli-Mayry,[...]. N Engl J Med 2008
903
13

Novel insight into the natural history of short QT syndrome.
Andrea Mazzanti, Ajita Kanthan, Nicola Monteforte, Mirella Memmi, Raffaella Bloise, Valeria Novelli, Carlotta Miceli, Sean O'Rourke, Gianluca Borio, Agnieszka Zienciuk-Krajka,[...]. J Am Coll Cardiol 2014
106
12

Risk of fatal arrhythmic events in long QT syndrome patients after syncope.
Christian Jons, Arthur J Moss, Ilan Goldenberg, Judy Liu, Scott McNitt, Wojciech Zareba, Ming Qi, Jennifer L Robinson. J Am Coll Cardiol 2010
72
16

Systematic review of the incidence of sudden cardiac death in the United States.
Melissa H Kong, Gregg C Fonarow, Eric D Peterson, Anne B Curtis, Adrian F Hernandez, Gillian D Sanders, Kevin L Thomas, David L Hayes, Sana M Al-Khatib. J Am Coll Cardiol 2011
178
12

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.
A V Postma, I Denjoy, J Kamblock, M Alders, J-M Lupoglazoff, G Vaksmann, L Dubosq-Bidot, P Sebillon, M M A M Mannens, P Guicheney,[...]. J Med Genet 2005
183
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.